Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Ohio for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Ohio only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Ohio (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Llewelyn Rao (NPI 1518165448)

Field	Value
Entity Type	Individual
Organization	Llewelyn Rao
Address	3401 Enterprise Pkwy
City	Beachwood
State	OH
ZIP	44122
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 3, 2007

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

LLEWELYN RAO is a retina specialist (Ophthalmology) physician based in BEACHWOOD, OH with lifetime Medicare revenue of $3.7M and no Medicaid billing on file. The provider’s NPI was enumerated on 2007-07-03 (~19 years ago), indicating a long-established practice presence in the Medicare market.

Revenue is highly concentrated in a small set of injectable drug codes: the precomputed top 3 Medicare codes by revenue account for 74.2% of this provider’s Medicare receipts. Specifically, J0178 accounts for 43.2% of Medicare revenue, J2777 for 24.5%, and J3490 for 6.5%, signaling heavy reliance on intravitreal pharmacologic treatments for the practice’s revenue base.

The mix of top codes (J0178, J2777, J3490) and frequent retinal procedure and imaging codes indicates an intravitreal-injection–focused retina practice that also provides diagnostic imaging and some surgical procedures. High-volume anti-VEGF and novel retinal therapeutics billing alongside codes for vitreous injections and retinal imaging suggests day-to-day operations centered on chronic retinal disease management and monitoring.

Competitive standing for the two largest drug codes is solid but not dominant nationally: J0178 ranks #403 of 3204 providers (87th percentile; typical, unremarkable volume) and J2777 ranks #284 of 2039 providers (86th percentile; typical, unremarkable volume). These placements indicate above-average activity for these agents compared with peers but not at an elite national scale.

The practice shows extreme national outlier volumes for diagnostic retinal services and intermediate-level established-patient exams, which points to a monitoring-heavy workflow. Code 92134 ranks #171 of 26868 providers (99th percentile; extreme outlier, far above typical national volume) and 92012 ranks #255 of 17177 providers (99th percentile; extreme outlier, far above typical national volume), implying unusually high throughput of retina imaging and follow-up visits relative to most ophthalmology providers.

There is evidence of adoption of newer and adjunctive retina therapeutics but with uneven uptake: J2781 (pegcetacoplan) contributes $176.4K (4.8% of Medicare revenue) and ranks #52 of 490 providers (89th percentile; typical, unremarkable volume), while J0179 (brolucizumab) represents $77.4K (2.1% of Medicare revenue) and ranks #44 of 64 providers (30th percentile; typical, unremarkable volume). This pattern suggests selective use of newer agents with stronger uptake for some drugs than others.

Surgical and procedural activity is present but secondary to injection and imaging revenue, consistent with a retina clinic that focuses on office-based therapies. For example, 67028 accounts for $177.8K (4.9% of Medicare revenue) and ranks #368 of 4255 providers (91th percentile; typical, unremarkable volume), while pars-plana vitrectomy and other retinal surgery codes appear at much smaller revenue shares, indicating modest operative volume compared with injections and diagnostics.

The payer mix is effectively single-payer at the provider level: Medicare drives the entire recorded public-payor revenue stream and Medicaid shows none on file. This concentration elevates exposure to Medicare reimbursement changes and suggests the provider’s patient panel or contractual footprint is largely Medicare-centric rather than balanced across public payers.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

31 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,290	$690	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	30,780	$30	$892.6K
J3490	Unclassified drugs	140	$1,760	$237.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,070	$90	$177.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,470	$120	$176.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,750	$30	$101.1K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	1,300	$60	$78.1K
J0179	Injection, brolucizumab-dbll, 1 mg	310	$250	$77.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	880	$80	$70.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	710	$80	$59.6K

Showing 1–10 of 31

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Ohio Distribution

Llewelyn Rao — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Ohio

Full comparison — all codes billed, vs. state median

31 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	100	840	$680	$729K
J2777	6	70	9,480	$30	$353.3K
J2781	6	20	1,040	$120	$152.4K
J0179	4	10	320	$250	$101.1K
J3490	17	50	100	$560	$73.1K
67028	7	150	470	$90	$64K
J7312	6	20	240	$160	$41.7K
J3590	33	100	200	$100	$30K
67042	24	50	20	$960	$29.7K
67108	16	30	20	$1,020	$26.5K

Showing 1–10 of 31

Related Providers

Other providers that share a Tax Identification Number (TIN) with Llewelyn Rao, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
New York Eye & Ear Infirmary	NY	Special Hospital	$0	$38.9M
Retina Associates Of Cleveland, Inc.	OH	Retina Specialist (Ophthalmology) Physician	$0	$11.2M
Scott Pendergast	OH	Retina Specialist (Ophthalmology) Physician	$6M	$0
Jonathan Feistmann	NY	Ophthalmology Physician	$2.7M	$3.1M
David Miller	OH	Retina Specialist (Ophthalmology) Physician	$4.8M	$0
Brian Campolattaro	NY	Pediatric Ophthalmology and Strabismus Specialist Physician Physician	$122.7K	$4.2M
Brooke Nesmith	KS	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Juan Romero	NY	Ophthalmology Physician	$3.1M	$441.8K
Joseph Coney	OH	Retina Specialist (Ophthalmology) Physician	$3.2M	$140
Arnold Nothnagel	OH	Retina Specialist (Ophthalmology) Physician	$2.9M	$0

Nearby Providers

Other providers in the same ZIP code as Llewelyn Rao, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Primary Care Practices Inc	OH	Internal Medicine Physician	$0	$78.7M
Pearl's Hope, LLC	OH	Home Health Agency	$0	$47.8M
Health Care Bridge, Inc	OH	Home Health Agency	$0	$32.3M
Cleveland Clinic Health System - East Region	OH	General Acute Care Hospital	$0	$31.5M
Altimate Care LLC	OH	Home Health Agency	$0	$24M
Signature Health, Inc	OH	Federally Qualified Health Center (FQHC)	$0	$23M
University Hospitals Ahuja Medical Center, Inc	OH	General Acute Care Hospital	$0	$21.1M
Shaker Clinic, LLC	OH	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$15.5M
Psychological & Behavioral Consultants, LLC	OH	Psychiatry Physician	$0	$14.9M
Northeast Home Health Services	OH	Home Health Agency	$0	$11.9M

Llewelyn Rao — Billing Profile & Reimbursement Data

Sign up for Llewelyn Rao — Billing Profile & Reimbursement Data policy alerts

Llewelyn Rao — Billing Profile & Reimbursement Data

Sign up for Llewelyn Rao — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References